KALPIT KAMLESH PATEL
** **. ********* ******, ***. 809, Boston, MA 02120 510-***-**** ***********.**@*****.*** LinkedIn: http://linkedin.com/in/kalpit-patel-13785210a Skype: ktplind ACADEMICS
Northeastern University, College of Professional Studies, Boston, MA. Jan 2017-Present Master of Science in Regulatory Affairs for Drugs, Biologics & Medical Device GPA 3.5/4 Gujarat Technological University, Sigma Institute of Pharmacy, Ahmedabad, India. Aug 2012-Jun 2016 Bachelor of Science in Pharmacy GPA 7.77/10
EXPERIENCE
Goverdhan Medico, Vadodara, India Jul-Oct 2016
Pharmacist
Interpreted prescriptions to dispense medicines with a touch of patient counselling.
Established excellent customer relationship through good interpersonal skills. Gujarat Liqui Pharmacaps Pvt. Ltd., Vadodara, India Jun-Aug 2015 Summer Internship
Got acquainted with the functioning of a Pharmaceutical industry and hands on experience on all aspects in a soft gelatin capsule making company.
Obtained sound knowledge in operations like measuring TDS for different types of water used in production, Bloom strength of gelatin, Quality control of finished product & packaging materials and Maintaining BMR’s. SKILLS
Regulatory: PREA waiver/deferral, AERS reports & Package insert analysis, Warning letter analysis, Clinical Trial forms, Clinical Study Reports, PMS.
Submissions- IND, 510(k), IDE, BLA, PMA, HDE, IVD, HUD, ANDA, NDA, eCTD.
Quality- GMP, GLP, GCP, QSR, CAPA, ISO 13485 (QMS), ISO 14971 (QRM).
Regulations- U.S. FDA, ICH, WHO.
Strategic Planning & Project Management- GHTF, IMDRF.
Computer: MS PowerPoint, Word, Excel, Outlook, Adobe Acrobat.
Communication: Spanish (Novice).
ACADEMIC PROJECTS
Due Diligence Research Project: RESURE SEALANT
Enacted as Regulatory consultant and researched through CDRH’s 510(k) clearance database to choose a product.
Prepared a presentation justifying why my device should be considered an asset for the company. Medical Device Submission Business Strategy
Prepared and presented 510(k) Medical Device Submission Business Strategy.
Accounted applicable CFRs & Guidance documents for my device. REVIEW PUBLICATIONS
1. ZIKA virus infection: threat to human life in European Journal of Pharmaceutical and Medical Research; Vol. 3, Issue 6, June 2016; Kalpit Patel, *Dr. Hitesh Jain, et. al. 2. Role of NEPRILYSIN inhibitors: combinations in cardiovascular disease in World Journal of Pharmaceutical Research; Vol. 5, Issue 5, May 2016; Kalpit Patel, *Dr. Jagdish Kakadiya, et. al. VOLUNTEER
American Red Cross, MA (once a month) Jul 2017-Present Blood Drive Donor Ambassador
Regulatory Affairs Professional Society (RAPS) Oct 2017-Present Social Media Outreach